Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Intralesional Nonavalent HPV Vaccine for Genital Condylomata in Adults: an Open Label Pilot Study

NCT05087849 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05087849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05087849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Intralesional Nonavalent HPV Vaccine for Genital Condylomata in Adults: an Open Label Pilot Study
Lead sponsor
University of California, San Francisco
Phase
Phase 1/2
Overall status
Completed
Start date
April 15, 2022
Completion date
July 1, 2024
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

condyloma, condylomata acuminata, human papilloma virus, warts, warts, genital